ValueAct Capital (Mason Morfit) Top Holdings of Q4 2025
| Ticker | Name | Shares | Value | % of Portfolio | Time Held | % Change |
|---|---|---|---|---|---|---|
| 2.99 M | $793.28 M | 11.29% | 3 Years | +3.31% | ||
| 3.39 M | $783.47 M | 11.15% | 1 Years | -3.03% | ||
| 39.38 M | $762.41 M | 10.85% | 0.75 Years | +55.07% | ||
| 695,000 | $743.89 M | 10.59% | New Buy | +100.00% | ||
| 1.05 M | $691.76 M | 9.85% | 1.3 Years | +36.34% | ||
| 1.72 M | $602.61 M | 8.58% | 1.3 Years | +9.73% | ||
| 1.41 M | $590.42 M | 8.40% | 0.5 Years | -33.59% | ||
| 5.98 M | $484.22 M | 6.89% | 2.3 Years | +39.52% | ||
| 3.08 M | $350.18 M | 4.98% | 2 Years | -29.92% | ||
| 3.6 M | $299.71 M | 4.27% | New Buy | +2.51% |
Recent Moves
ValueAct Capital (Mason Morfit)'s Historical Top Holdings Overview
Portfolio Date:
ValueAct Capital (Mason Morfit) Top Stock Picks
| Ticker | Name | Date | Activity | Shares | Shares Change | Value Change |
|---|---|---|---|---|---|---|
| 12/31/2025 | New Buy | 695,000 | 695,000 | $743.89 M | ||
| 12/31/2025 | Reduce -33.6% | 1.41 M | -711,400 | $298.57 M | ||
| 12/31/2025 | Add 55.1% | 39.38 M | 13.99 M | $270.75 M | ||
| 12/31/2025 | Sold Out | 0 | -904,800 | $190.72 M | ||
| 12/31/2025 | Add 36.3% | 1.05 M | 279,300 | $184.36 M | ||
| 12/31/2025 | Add 135.9% | 8.02 M | 4.62 M | $163.99 M | ||
| 12/31/2025 | Reduce -29.9% | 3.08 M | -1.31 M | $149.49 M | ||
| 12/31/2025 | Add 39.5% | 5.98 M | 1.69 M | $137.15 M | ||
| 12/31/2025 | Reduce -46.5% | 1.22 M | -1.06 M | $85.96 M | ||
| 12/31/2025 | Add 9.7% | 1.72 M | 152,400 | $53.45 M |
ValueAct Capital (Mason Morfit)'s Portfolio Sector Breakdown
Portfolio Date:
About ValueAct Capital (Mason Morfit)
Founded by Jeffrey Ubben, now led by Mason Morfit, ValueAct Capital is an activist investment firm based in San Francisco, co-founded by Jeffrey W. Ubben. The firm is known for its influential but generally non-confrontational approach to activism. They have a long track record of successfully working with companies across various industries, including Microsoft, Adobe, and Rolls-Royce, to drive long-term shareholder value.
Frequently Asked Questions
In Q4 2025, ValueAct Capital (Mason Morfit)’s largest purchase by dollar amount was BLK. For complete transaction details, please visit ValueAct Capital (Mason Morfit)’s portfolio.
According to the 13F filing for Q4 2025, ValueAct Capital (Mason Morfit) increased their stake in RKT.
ValueAct Capital (Mason Morfit)'s firm may occasionally request confidential treatment under SEC rule 13F-HR, which allows temporary non-disclosure of certain positions.
ValueAct Capital (Mason Morfit) Portfolio and Latest Trades
📑 This page provides a complete record of ValueAct Capital (Mason Morfit)’s stock and ETF transactions based on SEC Form 13F filings. All trades are listed in reverse chronological order, allowing investors to follow his historical buy and sell decisions across multiple decades.
| Ticker | Name | Date | Activity | Shares | Shares Change | Value Change |
|---|---|---|---|---|---|---|
| BLK | 12/31/2025 | New Buy | 695,000 | +695,000 | $743.89 M | |
| MDB | 12/31/2025 | Reduce -33.6% | 1.41 M | -711,400 | $298.57 M | |
| RKT | 12/31/2025 | Add 55.1% | 39.38 M | +13.99 M | $270.75 M | |
| COOP | 12/31/2025 | Sold Out | 0 | -904,800 | $190.72 M | |
| META | 12/31/2025 | Add 36.3% | 1.05 M | +279,300 | $184.36 M | |
| TOST | 12/31/2025 | Add 135.9% | 8.02 M | +4.62 M | $163.99 M | |
| DIS | 12/31/2025 | Reduce -29.9% | 3.08 M | -1.31 M | $149.49 M | |
| RBLX | 12/31/2025 | Add 39.5% | 5.98 M | +1.69 M | $137.15 M | |
| NSIT | 12/31/2025 | Reduce -46.5% | 1.22 M | -1.06 M | $85.96 M | |
| V | 12/31/2025 | Add 9.7% | 1.72 M | +152,400 | $53.45 M | |
| SSD | 12/31/2025 | Add 21.9% | 1.47 M | +264,200 | $42.66 M | |
| LYV | 12/31/2025 | Add 28.4% | 823,066 | +182,200 | $25.96 M | |
| CRM | 12/31/2025 | Add 3.3% | 2.99 M | +96,000 | $25.43 M | |
| AMZN | 12/31/2025 | Reduce -3.0% | 3.39 M | -106,200 | $24.51 M | |
| LLYVK | 12/31/2025 | Add 2.5% | 3.6 M | +88,100 | $7.33 M | |
| LLYVA | 12/31/2025 | Add 4.6% | 1.8 M | +79,771 | $6.5 M | |
| MDB | 09/30/2025 | Add 206.8% | 2.12 M | +1.43 M | $247.49 M | |
| RKT | 09/30/2025 | Add 67.9% | 25.4 M | +10.27 M | $199.03 M | |
| TOST | 09/30/2025 | New Buy | 3.4 M | +3.4 M | $124.03 M | |
| V | 09/30/2025 | Add 25.8% | 1.57 M | +320,900 | $109.55 M |
ValueAct Capital (Mason Morfit)'s Latest 13F Holdings
📑 This page provides a detailed view of ValueAct Capital (Mason Morfit)'s portfolio holdings based on official SEC Form 13F filings. Investors can review the latest quarter's positions and seamlessly switch between different quarters to explore how the portfolio has evolved over time.
Holdings are categorized into Stocks/ETFs, Options, Debt, and Other, with transaction markers such as New Buy, Add, Reduce, No Change, and Sold Out. Reported anomalies are corrected where possible, and share counts are adjusted to reflect corporate actions like stock splits.
In addition, we calculate the holding duration of each asset, allowing investors to see how long positions have been maintained across quarters. By exploring both current and historical holdings, users gain insights into turnover, portfolio concentration, asset allocation shifts, and the top stock and ETF positions of ValueAct Capital (Mason Morfit).
| Name | Shares | Value | % of Portfolio | Time Held | % Change | |
|---|---|---|---|---|---|---|
|
Loading holdings data... |
||||||
Note: Shares, Shares Change - split-adjusted.
ValueAct Capital (Mason Morfit)’s Quarterly 13F Portfolio History
📊 This page provides a historical view of ValueAct Capital (Mason Morfit)’s portfolio holdings based on official SEC Form 13F filings.
Explore how investments have evolved quarter by quarter, with insights into turnover rates, portfolio concentration, asset allocation shifts, and the firm’s top 10 stock and ETF positions.
| Quarter | Holdings | Total Value | Turnover Rate | Top 10 Stock & ETF Holdings |
|---|